Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization. Semin Intervent Radiol 2017 Jun;34(2):87-91

Date

06/06/2017

Pubmed ID

28579675

Pubmed Central ID

PMC5453773

DOI

10.1055/s-0037-1601854

Scopus ID

2-s2.0-85020204148   2 Citations

Abstract

Colorectal cancer is the third most common cancer in the United States and the liver is the most common site of metastatic disease. The presence and extent of hepatic metastases are a major prognostic indicator. Although surgical resection is the accepted first-line therapy for colorectal liver metastasis, only 20 to 25% of patients are eligible for resection due to the extent and location of disease. This article discusses the current role of transarterial therapies in the treatment of colorectal liver metastases.

Author List

Fairchild AH, White SB

Author

Sarah B. White MD, MS, FSIR, FCIRSE Vice Chair, Professor in the Radiology department at Medical College of Wisconsin